Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Novelix Pharmaceuticals Limited
Novelix Pharmaceuticals Limited, established in 1994, boasts 31 years of expertise in its field. It is registered under CIN L67120TG1994PLC018956 and registration number 18956. It falls under the category of company limited by shares. Its authorized share capital is ₹30.00 crore. Novelix Pharmaceuticals Limited reports paid-up capital of ₹17.22 crore.
The firm focuses on activities auxiliary to financial intermediation. This entity is registered in Hyderabad, India. Its official registered office is situated at Flat # 610, 6th Floor, H.no.3-6-237/610, Lingapur La Builders ( Also Known As Amrutha Estate), Himayathnagar, Hyderabad, Himayathnagar, Telangana, India, 500029. Novelix Pharmaceuticals Limited remains active and operational. The company’s Legal Entity Identifier (LEI) code is 8945002HROSD4VUIYY08. You can reach the company via email at info@trimurthidrugs.com. Key executives of the company are: Sachin Dinkar Sondkar (CFO) and Bhoomika Choudhary (CFO).
Company Overview
- CIN
- Date of Incorporation
- 13/12/1994
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 31/03/2024
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹30,00,00,000.00
- Paid up Capital
- ₹17,21,50,000.00
- Activity
- Activities Auxiliary TO Financial Intermediation
- info@trimurthidrugs.com
- PAN
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE314I01036 | NOVELIX PHARMACEUTICALS LIMITED EQ NEW F.V. RE.10/- | - | 12/10/2026 | NOVELIX PHARMA/SH VTG | ESVUFN |
| IN8314I01019 | NOVELIX PHARMACEUTICALS LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | NOVELIX PHARMA/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹152.18L | ₹18.57L | ₹22.37L | ₹17.42L | ₹0.00L |
| Net Debt | ₹136.33L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross PPE | ₹286.83L | ₹143.45L | ₹143.46L | ₹134.69L | ₹0.00L |
| Inventory | ₹1,443.22L | ₹84.32L | ₹119.45L | ₹82.06L | ₹0.00L |
| Total Debt | ₹432.19L | ₹0.00L | ₹0.00L | ₹0.00L | ₹16.45L |
| Common Stock | ₹2,108.50L | ₹995.00L | ₹810.00L | ₹810.00L | ₹0.00L |
| Current Debt | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹3.37L |
| Share Issued | ₹210.85L | ₹99.50L | ₹81.00L | ₹81.00L | ₹0.00L |
| Total Assets | ₹9,242.32L | ₹2,720.65L | ₹736.49L | ₹725.68L | ₹0.00L |
| Capital Stock | ₹2,108.50L | ₹995.00L | ₹810.00L | ₹810.00L | ₹0.00L |
| Long Term Debt | ₹432.19L | ₹0.00L | ₹0.00L | ₹0.00L | ₹13.08L |
| Current Assets | ₹8,891.12L | ₹2,693.29L | ₹412.98L | ₹424.27L | ₹0.00L |
| Prepaid Assets | ₹38.78L | ₹9.18L | ₹0.08L | ₹1.30L | ₹0.00L |
| Working Capital | ₹4,297.64L | ₹1,726.57L | ₹411.97L | ₹418.11L | ₹0.00L |
| Invested Capital | ₹4,648.84L | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹0.00L |
| Other Properties | ₹152.18L | ₹18.57L | ₹0.00L | ₹14.31L | ₹14.31L |
| Retained Earnings | ₹68.09L | -₹187.57L | -₹196.02L | -₹243.19L | ₹0.00L |
| Common Stock Equity | ₹4,648.84L | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹0.00L |
| Net Tangible Assets | ₹4,455.87L | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹0.00L |
| Tangible Book Value | ₹4,455.87L | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹0.00L |
| Current Liabilities | ₹4,593.48L | ₹966.72L | ₹1.01L | ₹6.16L | ₹0.00L |
| Stockholders Equity | ₹4,648.84L | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹0.00L |
| Other Equity Interest | ₹2,540.34L | ₹758.93L | -₹74.52L | ₹0.00L | ₹6.98L |
| Total Capitalization | ₹4,648.84L | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹0.00L |
| Investment Properties | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹173.88L |
| Ordinary Shares Number | ₹210.85L | ₹99.50L | ₹81.00L | ₹81.00L | ₹0.00L |
| Other Intangible Assets | ₹192.97L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Non Current Assets | -₹0.98L | -₹3.80L | -₹10.61L | ₹0.00L | ₹0.00L |
| Total Non Current Assets | ₹351.20L | ₹27.35L | ₹323.51L | ₹301.40L | ₹0.00L |
| Cash And Cash Equivalents | ₹295.86L | ₹67.86L | ₹11.78L | ₹27.47L | ₹0.00L |
| Construction In Progress | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Accumulated Depreciation | -₹134.65L | -₹124.88L | -₹121.08L | -₹117.27L | ₹0.00L |
| Additional Paid In Capital | ₹2,472.25L | ₹946.50L | ₹121.50L | ₹121.50L | ₹0.00L |
| Machinery Furniture Equipment | ₹272.52L | ₹129.14L | ₹129.15L | ₹120.38L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹192.97L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹4,648.84L | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹4,593.48L | ₹966.72L | ₹1.01L | ₹6.16L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹3.37L |
| Long Term Debt And Capital Lease Obligation | ₹432.19L | ₹0.00L | ₹0.00L | ₹0.00L | ₹13.08L |
| Cash Cash Equivalents And Short Term Investments | ₹295.86L | ₹67.86L | ₹261.78L | ₹277.47L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹0.00L | -₹0.01L | ₹0.00L | ₹0.00L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | -₹2,564.51L | -₹1,379.07L | -₹34.35L | -₹240.97L | ₹0.00L |
| Changes In Cash | ₹228.00L | ₹56.08L | -₹15.70L | -₹233.02L | ₹0.00L |
| End Cash Position | ₹295.86L | ₹67.86L | ₹11.79L | ₹27.47L | ₹0.00L |
| Financing Cash Flow | ₹2,639.25L | ₹1,131.50L | ₹0.00L | ₹0.00L | ₹0.00L |
| Investing Cash Flow | -₹172.34L | ₹293.04L | ₹18.65L | ₹7.51L | ₹0.00L |
| Operating Cash Flow | -₹2,238.91L | -₹1,368.46L | -₹34.35L | -₹240.53L | ₹0.00L |
| Capital Expenditure | -₹325.60L | -₹10.61L | ₹0.00L | -₹0.44L | -₹186.48L |
| Beginning Cash Position | ₹67.86L | ₹11.78L | ₹27.47L | ₹260.49L | ₹0.00L |
| Issuance Of Capital Stock | ₹2,639.25L | ₹1,131.50L | ₹0.00L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹342.74L | ₹12.33L | ₹2.23L | -₹57.39L | ₹0.00L |
| EBITDA | ₹352.85L | ₹16.13L | ₹6.04L | -₹51.77L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | -₹0.00L | ₹0.00L |
| Net Income | ₹255.66L | ₹8.45L | ₹1.04L | -₹5.99L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | -₹0.00L | ₹0.00L |
| Gross Profit | ₹559.14L | ₹114.48L | ₹38.75L | ₹5.24L | ₹0.00L |
| Pretax Income | ₹340.43L | ₹12.33L | ₹2.13L | -₹5.85L | ₹0.00L |
| Tax Provision | ₹84.77L | ₹3.88L | ₹1.08L | ₹0.15L | ₹0.00L |
| Total Revenue | ₹13,230.62L | ₹3,071.85L | ₹422.38L | ₹140.46L | ₹0.00L |
| Cost Of Revenue | ₹12,671.48L | ₹2,957.37L | ₹383.63L | ₹135.22L | ₹0.00L |
| Total Expenses | ₹12,882.79L | ₹3,028.97L | ₹435.43L | ₹197.85L | ₹0.00L |
| Interest Income | ₹0.07L | ₹1.59L | ₹20.44L | ₹27.27L | ₹0.00L |
| Interest Expense | ₹2.31L | ₹0.00L | ₹0.10L | ₹0.00L | ₹5.77L |
| Operating Income | ₹347.83L | ₹42.88L | -₹13.05L | -₹57.39L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹353.30L | ₹48.27L | ₹14.98L | -₹76.04L | ₹0.00L |
| Normalized Income | ₹256.00L | ₹30.48L | ₹7.30L | -₹22.98L | ₹0.00L |
| Operating Expense | ₹211.31L | ₹71.60L | ₹51.80L | ₹62.63L | ₹0.00L |
| Operating Revenue | ₹13,230.62L | ₹3,071.85L | ₹422.38L | ₹140.46L | ₹0.00L |
| Net Interest Income | -₹6.66L | ₹1.59L | ₹20.31L | ₹27.25L | ₹0.00L |
| Total Unusual Items | -₹0.45L | -₹32.14L | -₹8.94L | ₹24.27L | ₹0.00L |
| Basic Average Shares | ₹210.85L | ₹99.50L | ₹104.12L | ₹81.00L | ₹0.00L |
| Diluted Average Shares | ₹210.85L | ₹99.50L | ₹104.12L | ₹81.00L | ₹0.00L |
| Total Other Finance Cost | ₹4.42L | ₹0.00L | ₹0.03L | ₹0.03L | ₹0.01L |
| Other Operating Expenses | ₹70.45L | ₹34.42L | ₹15.61L | ₹15.03L | ₹0.00L |
| Reconciled Depreciation | ₹10.11L | ₹3.80L | ₹3.81L | ₹5.62L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹12,671.48L | ₹2,957.37L | ₹383.63L | ₹135.22L | ₹0.00L |
| Rent Expense Supplemental | ₹2.33L | ₹2.00L | ₹0.20L | ₹1.50L | ₹0.00L |
| Tax Effect Of Unusual Items | -₹0.11L | -₹10.11L | -₹2.68L | ₹7.28L | ₹0.00L |
| Interest Income Non Operating | ₹0.07L | ₹1.59L | ₹20.44L | ₹27.27L | ₹0.00L |
| Selling And Marketing Expense | ₹1.08L | ₹4.33L | ₹3.62L | ₹2.67L | ₹0.00L |
| Interest Expense Non Operating | ₹2.31L | ₹0.00L | ₹0.10L | ₹0.00L | ₹5.77L |
| Net Income Common Stockholders | ₹255.66L | ₹8.45L | ₹1.04L | -₹5.99L | ₹0.00L |
| Net Income Continuous Operations | ₹255.66L | ₹8.45L | ₹1.04L | -₹5.99L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹255.66L | ₹8.45L | ₹1.04L | -₹5.99L | ₹0.00L |
| General And Administrative Expense | ₹22.54L | ₹20.19L | ₹9.74L | ₹5.89L | ₹0.00L |
| Selling General And Administration | ₹23.62L | ₹24.52L | ₹13.36L | ₹8.56L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹0.45L | -₹32.14L | -₹8.94L | ₹24.27L | ₹0.00L |
| Net Non Operating Interest Income Expense | -₹6.66L | ₹1.59L | ₹20.31L | ₹27.25L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹255.66L | ₹8.45L | ₹1.04L | -₹5.99L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹255.66L | ₹8.45L | ₹1.04L | -₹5.99L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹255.66L | ₹8.45L | ₹1.04L | -₹5.99L | ₹0.00L |
Company Performance (FY23–FY26)
₹132.3 Cr₹99.2 Cr₹66.2 Cr₹33.1 Cr₹0
FY23FY24FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/04/2019 | Nishita Kalantri | *****2207C | Company Secretary | |
| 02/09/2024 | Venkateshwarlu Pulluru | 02076871 | Whole-time director | View other directorships |
| 02/09/2024 | Janardhan Das Kabra | 02386627 | Director | View other directorships |
| 12/02/2025 | Lakshman Samala | 10783725 | Director | View other directorships |
| 12/02/2025 | Sachin Dinkar Sondkar | *****0689J | CFO | |
| 12/04/2025 | Jivamohan Divakar Valluri | 09218013 | Director | View other directorships |
| 14/08/2025 | Mayuri Baidya | 11242323 | Director | View other directorships |
| 14/08/2025 | Gnana Prakash Gattu | 00517921 | Director | View other directorships |
| 23/10/2025 | Sridevi Belide | 10455373 | Additional Director | View other directorships |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 9
- Venkateshwarlu PulluruWhole-time director
- Gnana Prakash GattuDirector
- Mayuri BaidyaDirector
- Jivamohan Divakar ValluriDirector
- Lakshman SamalaDirector
- Janardhan Das KabraDirector
- Sridevi BelideAdditional Director
- Sachin Dinkar SondkarCFO
- Nishita KalantriCompany Secretary
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 16/10/2024 | Resignation letter-16102024 | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| AB9567182 | 07/11/2025 | ₹85,00,000.00 | Canara Bank |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dirc Investments Ltd. | L67120AS1985PLC002404 | 302 Frutos Tradecentre Srcb Road Guwahati Kamrup As 781001 In |
| Exel Capital Services Limited | L67120CH1989PLC009085 | # 1639near Fort Gate Manimajra, Chandigarh Ut, Chandigarh, India, 000000 |
| Inani Securities Limited | L67120AP1994PLC017583 | 5-8-352/15, Room No.15,ground Floor Chirag Ali Lane Raghavaratna Towers, Hyderabad, Andhra Pradesh, India, 000000 |
| Steel City Securities Limited | L67120AP1995PLC019521 | Steel City Heights, 50-81-18, Main Road, Seethammapeta, Dwarakanagar, Visakhapatnam, Visakhapatnam (urban), Andhra Pradesh, India, 530016 |
| Williamson Financial Services Limited | L67120AS1971PLC001358 | Export Promotion Industrial Park, Plot No 1, Amingaon, Kamrup, North Guwahati, Assam, India, 781031 |
Address
Flat # 610, 6th Floor, H.no.3-6-237/610, Lingapur La Builders ( Also Known As Amrutha Estate), Himayathnagar, Hyderabad, Himayathnagar, Telangana, India, 500029
Frequently Asked Questions
What is the incorporation date of Novelix Pharmaceuticals Limited?
The incorporation date of Novelix Pharmaceuticals Limited is 13/12/1994.
What is the authorized share capital and paid-up capital of Novelix Pharmaceuticals Limited?
The authorized share capital of Novelix Pharmaceuticals Limited is ₹30,00,00,000.00. The paid-up capital is ₹17,21,50,000.00.
Who are the current board members & directors of Novelix Pharmaceuticals Limited?
The current board member of Novelix Pharmaceuticals Limited are:
- Nishita Kalantri
- Sridevi Belide
- Mayuri Baidya
- Jivamohan Divakar Valluri
- Lakshman Samala
- Sachin Dinkar Sondkar
- Gnana Prakash Gattu
- Venkateshwarlu Pulluru
- Janardhan Das Kabra
What is the registered address of Novelix Pharmaceuticals Limited?
The registered address of Novelix Pharmaceuticals Limited is Flat # 610, 6th Floor, H.no.3-6-237/610, Lingapur La Builders ( Also Known As Amrutha Estate), Himayathnagar, Hyderabad, Himayathnagar, Telangana, India, 500029.
What is the Corporate Identification Number of Novelix Pharmaceuticals Limited?
The Corporate Identification Number of Novelix Pharmaceuticals Limited is L67120TG1994PLC018956.